LeishmanCeres Laboratory (GLP Compliance Certified), Unidad de Parasitología y Enfermedades Parasitarias, Facultad de Veterinaria, Universidad de Extremadura, Avda. de la Universidad s/n, 10003 Cáceres, Spain.
Vet Parasitol. 2013 Feb 18;192(1-3):118-28. doi: 10.1016/j.vetpar.2012.10.002. Epub 2012 Oct 9.
In this report an experimental model of Leishmania infantum (L. infantum) infection in dogs is described. The data presented are derived from an overall and comparative analysis of the clinical outcomes of three groups of dogs intravenously infected with 500,000 promastigotes on different dates (2003, 2006 and 2008). The parasites used for challenge were isolated from a dog having a patent form of leishmaniosis, classified as MCAN/ES/1996/BCN150 zymodeme MON-1. Late-log-phase promastigote forms derived from cultured amastigotes obtained from the spleen of the heavily infected hamsters were used for infection. Only one single infective dose was administered to each dog. After challenge, the animals were monitored for 12 months. To analyze the disease outcome, several biopathological, immunological and parasitological end-points were considered. The analysis of the infected dogs indicated that the development of the clinical disease was very similar in the three experimental challenges, as shown by the immune response, the parasite load and the clinical and histopathological lesions detected at necropsy. A high similarity was also observed between the disease development after the experimental challenge and the one reported to occur in endemic natural infection areas, as various degrees of susceptibility to the disease and even resistance were observed in the experimentally infected animals. We believe that this challenge model faithfully reproduces and mimics the course of a natural infection and that it could be used as a suitable tool for analyzing the efficacy of anti-Leishmania drugs and vaccines.
本报告描述了一种利什曼原虫(L. infantum)感染犬的实验模型。所呈现的数据源自于三组犬静脉内感染 500,000 个前鞭毛体(日期分别为 2003、2006 和 2008 年)的临床结果的总体和比较分析。用于挑战的寄生虫是从一只患有显性利什曼病的犬中分离出来的,该犬被归类为 MCAN/ES/1996/BCN150 基因型 MON-1。从受重度感染的仓鼠脾脏中获得的培养的无鞭毛体衍生的晚期对数期前鞭毛体形式被用于感染。每只犬仅给予一个单一的感染剂量。感染后,动物被监测 12 个月。为了分析疾病结果,考虑了几个生物病理学、免疫学和寄生虫学终点。对感染犬的分析表明,在三次实验性挑战中,临床疾病的发展非常相似,这表现在免疫反应、寄生虫负荷以及尸检时检测到的临床和组织病理学病变。在实验性感染动物中观察到对疾病的不同程度的易感性甚至抗性,这表明实验性挑战后的疾病发展与在流行地区发生的自然感染非常相似。我们认为该挑战模型忠实地再现并模拟了自然感染的过程,并且可以作为分析抗利什曼原虫药物和疫苗疗效的合适工具。